biomarker

Biomarker Signatures for Progressive Idiopathic Pulmonary Fibrosis
B Clynick, TJ Corte, HE Jo, I Stewart, IN Glaspole, C Grainge, TM Maher, V Navaratnam, R Hubbard, PMA Hopkins, PN Reynolds, S Chapman, C Zappala, GJ Keir, WA Cooper, AM Mahar, S Ellis, NS Goh, E De Jong, L Cha, DBA Tan, L Leigh, C Oldmeadow, EH Walters, RG Jenkins, Y Moodley
Cite
Percentage Grade 4 Tumour Predicts Outcome for Prostate Adenocarcinoma in Needle Biopsies from Patients with Advanced Disease: 10-Year Data from the TROG 03.04 RADAR Trial
B Delahunt, A Steigler, C Atkinson, D Christie, G Duchesne, L Egevad, D Joseph, DN Kenwright, J Matthews, JD Murray, C Oldmeadow, H Samaratunga, NA Spry, MC Thunders, H Hondermarck, JW Denham
Cite
The Receptor Tyrosine Kinase Trka Is Increased and Targetable in HER2-Positive Breast Cancer
N Griffin, M Marsland, S Roselli, C Oldmeadow, J Attia, MM Walker, H Hondermarck, S Faulkner
Cite
Neurotrophin Receptors TrkA, p75textsuperscriptNTR, and Sortilin Are Increased and Targetable in Thyroid Cancer
S Faulkner, P Jobling, CW Rowe, SM Rodrigues Oliveira, S Roselli, RF Thorne, C Oldmeadow, J Attia, CC Jiang, XD Zhang, MM Walker, H Hondermarck
Cite
ProNGF Is a Potential Diagnostic Biomarker for Thyroid Cancer
S Faulkner, S Roselli, Y Demont, J Pundavela, G Choquet, P Leissner, C Oldmeadow, J Attia, MM Walker, H Hondermarck
Cite